Nuwellis Inc (NUWE)
1.84
-0.96
(-34.29%)
USD |
NASDAQ |
Nov 05, 16:00
1.85
+0.01
(+0.54%)
After-Hours: 20:00
Nuwellis Research and Development Expense (Annual): 5.422M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.422M |
| December 31, 2022 | 4.342M |
| December 31, 2021 | 4.978M |
| December 31, 2020 | 3.668M |
| December 31, 2019 | 4.672M |
| December 31, 2018 | 3.053M |
| December 31, 2017 | 1.481M |
| December 31, 2016 | 8.109M |
| December 31, 2015 | 17.67M |
| December 31, 2014 | 16.87M |
| December 31, 2013 | 13.50M |
| Date | Value |
|---|---|
| December 31, 2012 | 8.003M |
| December 31, 2011 | 11.20M |
| June 30, 2011 | 5.318M |
| June 30, 2010 | 2.948M |
| June 30, 2009 | 2.519M |
| June 30, 2008 | 5.12M |
| June 30, 2007 | 8.732M |
| June 30, 2006 | 4.400M |
| June 30, 2005 | 2.444M |
| June 30, 2004 | 0.4615M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.668M
Minimum
2020
5.422M
Maximum
2023
4.616M
Average
4.672M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Hologic Inc | 294.30M |
| Varex Imaging Corp | 84.80M |
| Quanterix Corp | 24.86M |
| Electromed Inc | 0.656M |
| Myomo Inc | 2.636M |